Sign Up to like & get
recommendations!
0
Published in 2017 at "International Immunopharmacology"
DOI: 10.1016/j.intimp.2017.06.009
Abstract: Abstract Triggered by the successful administration of the proteasome inhibitor bortezomib in kidney transplant recipients with acute or chronic antibody‐mediated rejection, we evaluated the effect of the proteasome inhibitor CEP‐18770 and of the selective immunoproteasome…
read more here.
Keywords:
alloimmunity;
inhibitor;
proteasome;
immunoproteasome ... See more keywords